Episode Details

Ahold Delhaize is paying $40 million after federal authorities accused the grocery giant of misreporting prescription drug prices to Medicare and Medicaid, causing those programs to overpay. A former pharmacist tipped off regulators, earning him $6 million. The bulk of the settlement goes to the federal government, with states splitting the rest. Ahold Delhaize denies wrongdoing but admits full cooperation, noting these billing issues relate to programs discontinued nearly a decade ago. The settlement arrives just as the company grapples with new healthcare costs from the Inflation Reduction Act. This isn’t an isolated case—CVS and Walgreens have also faced scrutiny over pricing and billing practices, revealing a tangled system that directly affects taxpayer-funded healthcare spending.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/422f47ddd3f49a67